AQR Capital Management
UTMD icon

AQR Capital Management’s Utah Medical Products UTMD Stock Holding History

AQR Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
14,993
+4,722
+46% +$314K ﹤0.01% 2985
2026
Q1 		$637K Sell
10,271
-378
-4% -$23.8K ﹤0.01% 3006
2025
Q4 		$596K Sell
10,649
-4,757
-31% -$276K ﹤0.01% 2821
2025
Q3 		$970K Buy
15,406
+6,786
+79% +$401K ﹤0.01% 2451
2025
Q2 		$491K Buy
+8,620
New +$469K ﹤0.01% 2620
2024
Q4 		– Sell
-8,874
Closed -$594K – 2963
2024
Q3 		$594K Buy
8,874
+1,723
+24% +$117K ﹤0.01% 2085
2024
Q2 		$478K Buy
+7,151
New +$487K ﹤0.01% 2072
2022
Q3 		– Sell
-5,346
Closed -$459K – 2326
2022
Q2 		$459K Buy
5,346
+2,218
+71% +$189K ﹤0.01% 1711
2022
Q1 		$281K Buy
+3,128
New +$288K ﹤0.01% 1977
2021
Q1 		– Sell
-4,840
Closed -$408K – 2267
2020
Q4 		$408K Sell
4,840
-9,234
-66% -$787K ﹤0.01% 1859
2020
Q3 		$1.12M Sell
14,074
-58
-0.4% -$4.81K ﹤0.01% 1363
2020
Q2 		$1.25M Sell
14,132
-225
-2% -$20.2K ﹤0.01% 1373
2020
Q1 		$1.35M Buy
14,357
+281
+2% +$26.1K ﹤0.01% 1221
2019
Q4 		$1.52M Sell
14,076
-3,742
-21% -$379K ﹤0.01% 1373
2019
Q3 		$1.71M Sell
17,818
-220
-1% -$20.4K ﹤0.01% 1333
2019
Q2 		$1.73M Sell
18,038
-1,416
-7% -$119K ﹤0.01% 1319
2019
Q1 		$1.72M Sell
19,454
-2,617
-12% -$230K ﹤0.01% 1373
2018
Q4 		$1.83M Sell
22,071
-7,279
-25% -$641K ﹤0.01% 1281
2018
Q3 		$2.77M Buy
29,350
+27,286
+1,322% +$2.61M ﹤0.01% 1249
2018
Q2 		$227K Buy
+2,064
New +$216K ﹤0.01% 2192

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management's UTMD Position: Q2 2026 in Review

AQR Capital Management increased its Utah Medical Products (UTMD) stake by 46% in Q2 2026, buying an estimated $314K and bringing the position to 14,993 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

AQR Capital Management first reported a position in UTMD in Q2 2018 and has held it in 20 quarters since. The position peaked at $2.77M in Q3 2018. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • AQR Capital Management held 14,993 shares of Utah Medical Products worth $1.03M as of Q2 2026.
  • AQR Capital Management bought 4,722 Utah Medical Products shares in Q2 2026, an estimated $314K.
  • Utah Medical Products made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2985 holding.
  • AQR Capital Management first reported a position in Utah Medical Products in Q2 2018 and has held it in 20 quarters since.
  • AQR Capital Management's Utah Medical Products position peaked at $2.77M in Q3 2018.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.